N/A
Completed N=1,102
Patients and Health Staff of Cancer Centres During the Covid-19 Pandemic
Source: ClinicalTrials.gov NCT04421625 ↗Enrolled (actual)
1,102
Serious AEs
0.0%
Results posted
Dec 2025
Primary outcomePrimary: Number and Severity of Confirmed COVID-19 Infections Among Cancer Centre Staff and Patients at 12 Months — 55; 36 Participants
Summary
The Covid-19 has, in a few weeks, made the world tremble: the number of deaths (mainly elderly and / or co-morbid) continues to increase, the confinement causes the collapsing of the economy and the decline of relationships inter-human. The data are too fragmented and the disease too recent to know its repercussions on the 3 million French people who have or have had cancer. The investigators would like, in 3 populations: * patients in treatment, * or in follow-up and * health personnel, to constitute a large prospective and longitudinal database of data: i / serological: humoral response, test performance, monitoring of serum immunoglobulin levels , reinfection threshold,…; ii / clinical: incidence, severity, mortality and their favorable factors impact of cancer treatment on Covid-19 infection and modification of the quality of oncological care in the context. In parallel, on a more limited sample of establishments, it will be : * appreciate the economic and functional repercussions, * will try to find out about the infection modalities in patients and health personnel and * will appreciate the levels of anxiety and depression to which health staff are subject.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number and Severity of Confirmed COVID-19 Infections Among Cancer Centre Staff and Patients at 12 Months |
55; 36 | — |
Eligibility Criteria
Inclusion Criteria
- Age >= 18 years
- Population in Cancer centres responding to one of these 3 definitions: patients having a treatment in process, patients under surveillance ( having completed their treatment for more than a year), health staff.
- Subjects who may or may not have had an infection compatible or proven with a Covid-19 infection.
- Information to the participants and signature of the informed consent.
- Subject affiliated with a social insurance
Exclusion Criteria
- Refusal of consent
- Patients who are unable to consent or have a psychiatric history
- Inability to submit to the medical follow-up of the study for geographical, social or psychological reasons
- Person under guardianship or protection of vulnerable adults
- Person deprived of liberty by a judicial or administrative decision
Data sourced from ClinicalTrials.gov (NCT04421625). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.